Our vision in MBCP is to improve patient quality of life through clinical research. We know that pelvic floor dysfunction and defecation disorders can have a dramatic effect on one's daily activities and overall quality of life. The knowledge gained through this research will then be used to more accurately diagnose and more effectively treat this previously under recognized and underserved patient population.
Research by Doctor
- Mitchell Berger, M.D., Ph.D.
- William Chey, M.D.
- Shanti Eswaran, M.D.
- Dee Fenner, M.D.
- Karin Hardiman, M.D.
- Stacy Menees, M.D.
- Gianna Rodriguez, M.D.
- Richard Saad, M.D.
Active Research Projects
- Comparing the Effectiveness of Two Dietary Interventions for Fecal Incontinence: A Randomized, Controlled Trial
This study is randomizing patients with Fecal Incontinence (at least 1 accident of loose stools per week for 2 consecutive weeks) to either a low FODMAP or a high fiber supplement diet. We will be taking stool samples and surveys to assess change.
- Creating a Patient Symptom and Food Consumption Reporting Mobile Application
This study is researching the use of a mobile app to record GI symptoms one week before and one week after a visit to a GI dietician. Please contact Kenya Jackson, study coordinator (firstname.lastname@example.org) if you have an upcoming appointment and are interested in volunteering for this study.
FODMAPs are carbohydrates thought to worsen symptoms of IBS, and a diet low in FODMAPs can help IBS symptoms. The purpose of the study is to find out if a diet low in all FODMAPs is necessary to result in symptom improvement, or if less restrictive low FODMAP diet will be sufficient.
This study is randomizing IBS-D patients to receive either rifaximin or a low FODMAP diet and follow their fecal microbiota and hydrogen breath testing results.
Functional dyspepsia (FD) is an extremely common disorder of the stomach/gut, however the exact cause of the disorder at the cellular level is poorly understood. The goal of this study is to compare cells taken from the gut of functional dyspepsia patients to those taken from healthy volunteers.
This is an open label study where subjects will be placed on olanzapine and then followed for 8 weeks to determine if this improves their symptoms. They will also have gastric emptying tests performed by wireless motility capsule before and after treatment.
- The Prevalence and Impact of Lower Gastrointestinal Symptoms in an Ambulatory Elderly Outpatient Population
- Do Constipation Symptoms Predict Dyssynergic Defecation as Defined by Anorectal Manometry
- Advancing Age is Associated with Progressive Delays in Colon Transit in Patients with Chronic Constipation
- Anorectal Manometry Parameters in a Fecal Incontinence Cohort Related to Body Mass Index
- Bowel Dysfunction Associated with Parkinson Disease
- Cost Utility Analysis of Biofeedback versus Traditional Therapy for Dyssynergic Defecation in Adults
- Dyssynergic Defecation is a Common Finding in Men with Chronic Constipation
- Effects of Age and Gender in Anorectal Manometry Related with Fecal Incontinence
- Effects of Age and Gender on Anorectal Findings in Chronic Constipation
- Factors associated with Quality of Life among Women with Fecal Incontinence
- Impairment of Overall and Regional High Amplitude Colon Contractions in Severe Slow Transit Constipation Measured by Wireless Motility Capsules
- Is Biofeedback Therapy Superior to Standard Treatment for Patients with Dyssnergic Defecation: Results from A Meta-Analysis
- The number of retained rectosigmoid markers during colonic transit testing does not reliably predict the presence of Dyssynergic Defecation
- Relation of Wireless Motility Capsule Gastric Emptying Times and Gastrointestinal Pressure Parameters to Symptom Reports in Gastroparesis: The Search for a Motor Cause of Symptoms
- What are the Key Questions Which Aid in the Diagnosis of Dyssynergic Defecation